Previously known as Meaningful Use Stage 3, CMS renamed the EHR Incentive Programs to Promoting Interoperability in April 2018. The program has evolved over time as providers have adopted EHRs and is focused on interoperability across EHRs and improving patient access to health information, hence the name Promoting Interoperability.
At time of attestation you will need a screenshot of the QIC and a download of the SQL to a CSV file. All information should be saved to your "Book of Evidence". This can be an electronic folder of all documentation for the reporting period.
Objective 8: Public Health and Clinical Data Registry Reporting
Objective 8 requires a practice to attest the eligible professional is in active engagement with a public health agency or clinical data registry. The eligible professional must meet two of the five measures for this objective.
Measure 1: Immunization Registry Reporting
- Must be in active engagement to submit immunization data and receive immunization forecasts and histories from the immunization registry.
Measure 2: Syndromic Surveillance Reporting
- Must be in active engagement with a public health agency to submit syndromic surveillance data.
Measure 3: Electronic Case Reporting
- Must be in active engagement with a public health agency to submit case reporting of reportable conditions.
Measure 4: Public Health Registry Reporting
- Must be in active engagement with a public health agency to submit data to a public health registry.
Measure 5: CDR (Clinical Data Registry) Reporting
- Must be in active engagement to submit data to a Clinical Data Registry.
Note: Exclusions for all Measures: May take an exclusion if any of the following apply.
Objective 7/Measure 1:
Objective 7/Measure 2:
Objective 7/Measure 3:
Objective 7/Measure 4:
Objective 7/Measure 5:
Active Engagement Options
Completed Registration to Submit Data: The EP registered to submit data with the PHA or, where applicable, the CDR to which the information is being submitted; registration was completed within 60 days after the start of the EHR reporting period; and the EP is awaiting an invitation from the PHA or CDR to begin testing and validation. This option allows providers to meet the measure when the PHA or the CDR has limited resources to initiate the testing and validation process. Providers that have registered in previous years do not need to submit an additional registration to meet this requirement for each EHR reporting period.
Testing and Validation: The EP is in the process of testing and validation of the electronic submission of data. Providers must respond to requests from the PHA or, where applicable, the CDR within 30 days; failure to respond twice within an EHR reporting period would result in that provider not meeting the measure.
Production: The EP has completed testing and validation of the electronic submission and is electronically submitting production data to the PHA or CDR.
Note: For any entity that the practice would like to exchange data with as it pertains to Public Health Reporting or Syndromic Surveillance, it is the practice's responsibility to enter into Active Engagement under one of the three options above. Once the practice is in Active Engagement Option 2 you will need to submit an interface request with the Client Account Management Team. Office Practicum will provide a quote, and manage it like all other interface requests. The practice will incur a charge for the interface unless it was included as part of the original contract. In addition, Office Practicum will require time to develop the interface.